← Open Payments lookup

MARTINS AZIENGBE: Open Payments

NPI 1659618908 · WASHINGTON, DC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$363 in 11 payments from 6 companies in 2025. Trend: 2023 $0 · 2024 $88 · 2025 $363

Food & beverage: $363
CompanyPaymentsAmount
Novo Nordisk Inc2$142
GlaxoSmithKline, LLC.3$86
Boehringer Ingelheim Pharmaceuticals, Inc.3$78
Phadia US Inc.1$22
ABBVIE INC.1$18
E.R. Squibb & Sons, L.L.C.1$16

Products named: Ozempic, JARDIANCE, TRELEGY ELLIPTA, AREXVY, ImmunoCAP, VRAYLAR, COBENFY.

Industry payments across DC — which companies pay providers there.